Health - Latest News Search Engine - Global and Local Breaking News

Health

Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy

TAMPA, Fla., April 10, 2025 /PRNewswire/ -- Joseph Spine Institute, led by renowned spine surgeon Dr. Samuel A. Joseph, Jr., proudly announces the gra...

Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy

Empowered with Meg Ryan Explores a Vision for Change with Seva Foundation

FORT LAUDERDALE, Fla., April 10, 2025 /PRNewswire/ -- Discover how Seva Foundation is transforming lives by empowering communities to combat preventab...

Empowered with Meg Ryan Explores a Vision for Change with Seva Foundation

Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology

The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecula...

Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology

Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results

VADUZ, Liechtenstein, April 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into...

Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results

Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models

GUANGZHOU, China, April 9, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provide...

JNCCN 最新研究發現，胰腺癌病人在治療和存活時間上存在明顯差異

Ohio State University Wexner Medical Center 和 James Comprehensive Cancer Center 的研究人員發現，對社會上較弱勢的轉移性胰臟癌病人而言，接受優質照護的機會明顯較低，存活率也較低。賓夕法尼亞州普利茅斯會議2025年4月10...

JNCCN 最新研究發現，胰腺癌病人在治療和存活時間上存在明顯差異

Harbour BioMed Appoints Youchen Chen as Chief Financial Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , April 9, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company...

Harbour BioMed Appoints Youchen Chen as Chief Financial Officer

Amcor builds cutting-edge coating facility, enhancing healthcare packaging access in Asia Pacific

New facility enhances supply chain security, reduces lead times and supports customers' growth First in Asia equipped with advanced air knife coating ...

Amcor builds cutting-edge coating facility, enhancing healthcare packaging access in Asia Pacific

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medica...

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

Plastic Surgery Center of Hampton Roads Celebrates 30 Years of Aesthetic Excellence

HAMPTON ROADS, Va., April 9, 2025 /PRNewswire/ -- This year marks the 30th anniversary of the Plastic Surgery Center of Hampton Roads (PSCHR), a trust...

Plastic Surgery Center of Hampton Roads Celebrates 30 Years of Aesthetic Excellence

Acurion Unveils Rebrand, New Leadership Team, and Series A Fundraising Launch

LA JOLLA, Calif., April 9, 2025 /PRNewswire/ -- Acurion, formerly known as io9, today announced its official rebranding as part of a strategic initiat...

Acurion Unveils Rebrand, New Leadership Team, and Series A Fundraising Launch

Merkel Cell Carcinoma Market to Grow Rapidly at a CAGR of 8.7% During the Study Period (2020-2034) | DelveInsight

The Merkel cell carcinoma market is poised for steady growth, with a strong CAGR projected from 2024 to 2034. This expansion across the 7MM will be dr...

Merkel Cell Carcinoma Market to Grow Rapidly at a CAGR of 8.7% During the Study Period (2020-2034) | DelveInsight

Saliva test may turn tide on prostate cancer, claim scientists

Analysing DNA in saliva can identify men at the greatest risk of prostate cancer

Saliva test may turn tide on prostate cancer, claim scientists

Primis Financial Corp. Receives Nasdaq Notice Regarding Delayed 10-K Filing

MCLEAN, Va., April 9, 2025 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") announced today that, as expected, it rec...

Primis Financial Corp. Receives Nasdaq Notice Regarding Delayed 10-K Filing

Delavie Sciences Unveils New Ingredient Hydrolytic Enzyme Complex: A Breakthrough in Skincare Science

This revolutionary ingredient targets oil control, elasticity, and skin renewal—without compromising barrier health. NEW YORK, April 9, 2025 /PRNewswi...

Delavie Sciences Unveils New Ingredient Hydrolytic Enzyme Complex: A Breakthrough in Skincare Science

VCI BIOFUELS GROUP SIGNS DEFINITIVE MERGER AGREEMENT WITH INTERNATIONAL MEDIA ACQUISITION CORP. TO PUBLICLY LIST ON THE NASDAQ

NEW YORK, April 9, 2025 /PRNewswire/ -- The Vietnamese ethanol production company, Vietnam Biofuels Development Joint Stock Company and its affiliates...

VCI BIOFUELS GROUP SIGNS DEFINITIVE MERGER AGREEMENT WITH INTERNATIONAL MEDIA ACQUISITION CORP. TO PUBLICLY LIST ON THE NASDAQ

REP Fitness Flexes in Europe's Top Market: Plans Direct-to-Consumer Launch in the UK

LONDON, April 9, 2025 /PRNewswire/ -- REP Fitness, the Colorado-based strength brand renowned for its innovative, high-quality gym equipment, today an...

REP Fitness Flexes in Europe's Top Market: Plans Direct-to-Consumer Launch in the UK

Encompass Health announces change in the time of 2025 first quarter earnings call

BIRMINGHAM, Ala., April 9, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has changed the time of its 2025 first quarter e...

Encompass Health announces change in the time of 2025 first quarter earnings call

Bon Secours Mercy Health, Inc. Announces Tender Pricing Information

CINCINNATI, April 9, 2025 /PRNewswire/ -- Bon Secours Mercy Health, Inc. ("BSMH") today announced tender pricing information. Pursuant to the Offer to...

Bon Secours Mercy Health, Inc. Announces Tender Pricing Information

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences

Aggregate cash dividend of $69.6 million, or an estimated $2.40 per share WALTHAM, Mass., April 9, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc. (N...

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences